These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9198853)

  • 41. [Experimental methods in hepatology. Guidelines of the German Work Group for Study of the Liver. Therapy of ascites in liver diseases. German Work Group for Study of the Liver].
    Gerbes AL
    Z Gastroenterol; 1997 Apr; 35(4):295-300. PubMed ID: 9221613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of surgical therapy in management of intractable ascites.
    Elcheroth J; Vons C; Franco D
    World J Surg; 1994; 18(2):240-5. PubMed ID: 8042329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Is diuretic-resistant ascites reversible in patients with liver cirrhosis amd portal hypertension?].
    Mansurov AA; Nazyrov FG; Akilov KhA; Ibadov RA; Karimov USh
    Klin Khir; 1998; (11):48-9. PubMed ID: 10077928
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of ascites in patients with cirrhosis. What to do when diuretics fail.
    Porayko MK; Wiesner RH
    Postgrad Med; 1992 Dec; 92(8):155-8, 161-6. PubMed ID: 1454665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatogenic ascites: pathogenesis and management.
    Pearlman DM
    N Y State J Med; 1968 Jul; 68(13):1837-42. PubMed ID: 4873502
    [No Abstract]   [Full Text] [Related]  

  • 46. Peritoneovenous shunts--devices of last resort.
    Shepherd KE; Miller BJ
    Can J Surg; 1988 Nov; 31(6):444-7. PubMed ID: 3179855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ascites].
    Jeong SW
    Korean J Gastroenterol; 2018 Aug; 72(2):49-55. PubMed ID: 30145856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ascites in Children.
    Bavdekar A; Thakur N
    Indian J Pediatr; 2016 Nov; 83(11):1334-1340. PubMed ID: 27278239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Peritoneovenous shunt in the treatment of persistent ascites in patients with portal hypertension].
    Patsiora MD; Lebezev VM
    Klin Med (Mosk); 1983 May; 61(5):66-8. PubMed ID: 6876704
    [No Abstract]   [Full Text] [Related]  

  • 50. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation.
    Orug T; Soonawalla ZF; Tekin K; Olliff SP; Buckels JA; Mayer AD
    Br J Surg; 2004 Jun; 91(6):769-73. PubMed ID: 15164449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transjugular intrahepatic porto-systemic shunt to relieve refractory ascites in a patient with cirrhosis and portal hypertension.
    Joseph G; George OK; Jayanthi V
    Indian Heart J; 2002; 54(6):731-2. PubMed ID: 12674194
    [No Abstract]   [Full Text] [Related]  

  • 53. Management of ascites in patients with chronic liver disease.
    Aiza I; Perez GO; Schiff ER
    Am J Gastroenterol; 1994 Nov; 89(11):1949-56. PubMed ID: 7942716
    [No Abstract]   [Full Text] [Related]  

  • 54. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience.
    Hussain FF; Meer ZF; Lopez AJ
    Cardiovasc Intervent Radiol; 2004; 27(4):325-8. PubMed ID: 15346206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
    Inoue J; Mori Y; Kawamura T
    Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant ascites: demographics, therapeutic efficacy and predictors of survival.
    Mackey JR; Venner PM
    Can J Oncol; 1996 Nov; 6(2):474-80. PubMed ID: 12056099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Complications and reoperations after peritoneo-atrial shunting in patients with liver cirrhosis and diuretic-resistant ascites].
    Vakhidov AV; Nazyrov FG; Akilov KhA; Deviatov AV; Mansurov AA
    Klin Khir (1962); 1991; (9):10-2. PubMed ID: 1766164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease.
    Vadeyar HJ; Doran JD; Charnley R; Ryder SD
    Br J Surg; 1999 Jul; 86(7):882-5. PubMed ID: 10417558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.